COSMOS Pharmaceutical Corporation

Tokyo Stock Exchange 3349.T

COSMOS Pharmaceutical Corporation Gross Profit for the year ending May 31, 2024: USD 1.20 B

COSMOS Pharmaceutical Corporation Gross Profit is USD 1.20 B for the year ending May 31, 2024, a -1.14% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.

COSMOS Pharmaceutical Corporation Gross Profit for the year ending May 31, 2023 was USD 1.21 B, a 2.93% change year over year.
COSMOS Pharmaceutical Corporation Gross Profit for the year ending May 31, 2022 was USD 1.18 B, a -11.16% change year over year.
COSMOS Pharmaceutical Corporation Gross Profit for the year ending May 31, 2021 was USD 1.32 B, a 5.75% change year over year.
COSMOS Pharmaceutical Corporation Gross Profit for the year ending May 31, 2020 was USD 1.25 B, a 11.34% change year over year.

Key data

Date	Gross Profit	Operating Income	EBIT	EBITDA

Tokyo Stock Exchange: 3349.T

COSMOS Pharmaceutical Corporation

CEO	Mr. Hideaki Yokoyama
IPO Date	Nov. 11, 2004
Location	Japan
Headquarters	Fukuoka Daiichi Building
Employees	5,512
Sector	Health Care
Industries Drugstores & Retail Pharmacies Pharmaceuticals Specialty Retail

Description

COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. It also operates 1,130 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. The company was founded in 1983 and is headquartered in Fukuoka, Japan.

Key trends

Past 5 years